Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2023/02/049505
CTRI/2023/02/049505RecruitingPhase 3

A Randomized Controlled Trial On Effect Of Kumaryadi Bidalaka In Comparison With CARBOXYMETHYLCELLULOSE Eye drops In The Treatment Of Digital Eye Strain W.S.R To SHUSHAKSHIPAKA.

Dr. Priya Bhardwaj1 site in 1 country78 target enrollmentStarted: August 2, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
78
Locations
1
Primary Endpoint
This study may provide use of kumaryadi Bidalaka as an effective treatment in relieving the symptoms of Digital Eye Strain.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study is an open label randomized controlled trial in which patients of Digital Eye strain would be taken from shalakyatantra opd no. 11 of shri Ayuved Mahavidyalaya Nagpur. Kumaryadi bidalaka will be given to the trial group for 15 days and Carboxymethylcellulose eyedrop will be given to the control group for 15 days and the results would be  compared on 30 th day. This study may provide use of kumaryadi Bidalka as an effective treatment in relieving the symptoms of digital eye strain and could be found effective in increasing the tear production.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Open Label

Eligibility Criteria

Ages
16.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •a)Patients having signs & symptoms of Digital Eye Strain.
  • •b)Patients having age group of 16-60 years irrespective of their sex, caste, economical status & residence status.
  • •c)Patients willing for treatment.
  • •d)Patients having normal vision with or without spectacles.

Exclusion Criteria

  • •a)Patients not willing for clinical trial.
  • •b)Patient suffering from other systematic disorders.
  • •c)Patient undergone any intra ocular & extra ocular surgeries.
  • •d)Patients having any ocular infectious /inflammatory disorders.

Outcomes

Primary Outcomes

This study may provide use of kumaryadi Bidalaka as an effective treatment in relieving the symptoms of Digital Eye Strain.

Time Frame: 1 month

Secondary Outcomes

  • Kumaryadi Bidalaka could be found effective in increasing the tear production by stimulating tear glands which are present in eyelids .(1 month)

Investigators

Sponsor
Dr. Priya Bhardwaj
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 2
To Study the Effect of Krushnajeerakadi yog charvan in Mukhapak w.s.r. to Stomatitis.
CTRI/2025/04/084543Dr Pranali Gajanan Sawarkar80
Not yet recruiting
Phase 2/3
A clinical study to see the effect of some Ayurvedic formulation in the form of Anjana application in the treatment of Praklinna Vartma
CTRI/2021/07/035017Sane Guruji Arogya Kendra60
Completed
Not Applicable
The Effects of a Large Language Model on Clinical Questioning SkillsGlaucomaCataractDiabetic RetinopathyKeratitisConjunctivitis
NCT06229379Sun Yat-sen University84
Not yet recruiting
Phase 2/3
A clinical trial to see the effect of some Ayurvedic formulation in the form of topical application in the treatment of Shushkakshipaka with reference to dry eye
CTRI/2021/02/031492Sane Guruji Arogya Kendra60
Not yet recruiting
Phase 2
To Evaluate The Efficacy of Dhatrayadi Rasakriya and Triphaladi Ghana Vati In Kacha With Special Reference To Immature Senile Cataract
CTRI/2023/08/056376National Institute of Ayurveda30